Clinical Outcomes After Biologic Initiation in Asthma With and Without Allergic Bronchopulmonary Aspergillosis
Year: 2026
Type: article
Abstract: Summary Primary matched analysis showed no statistically distinguishable excess one‐year asthma exacerbation risk with coded ABPA. Biomarker‐independent and recent‐ABPA analyses were consistent; exploratory steroid and pneumonia findings require caution.
Source: Clinical & Experimental Allergy
DOI: 10.1111/cea.70483
Authors: Adeel Nasrullah(Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Writing – original draft, Writing – review & editing), Humza Saeed(Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing), Usama Shujaatullah Khan(Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing), Ahmed Mahmoud(Investigation, Methodology, Writing – original draft, Writing – review & editing), Navneet Gupta(Investigation, Methodology, Writing – original draft, Writing – review & editing), Zayaan A. Adrish(Investigation, Methodology, Writing – original draft, Writing – review & editing), Abu Baker Sheikh(Data curation, Formal analysis, Investigation, Methodology, Supervision, Writing – review & editing)
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,760
OpenAlex ID: W7216290332
